1.2 Maternal Health Conditions & Prenatal Risk Factors

1.2 Maternal Health Conditions & Prenatal Risk Factors

Clinical Pearl & Core Takeaway: Neonatal transition begins long before delivery. Maternal pathophysiologic states directly alter the intrauterine environment, placental perfusion, and fetal organogenesis. Low-risk neonatal nurses must proactively identify prenatal risk factors during admission to anticipate resuscitation needs, identify hidden congenital anomalies, and prevent metabolic decompensation.

---

Maternal Diabetes Mellitus & Neonatal Pathophysiology

Diabetes in pregnancy is classified using White's Classification, which distinguishes between gestational diabetes mellitus (GDM) and pre-existing pregestational diabetes mellitus (Type 1 or Type 2) with or without secondary end-organ vascular complications.

White's Classification in Pregnancy

Teratogenicity vs. Fetal Hyperinsulinism

A critical distinction in neonatal pathophysiology is the timing of maternal hyperglycemia:

1. Early Pregnancy Hyperglycemia (Organogenesis, Weeks 3–8): Glucose is a potent teratogen during embryonic organogenesis. Poorly controlled pregestational diabetes with elevated maternal Hemoglobin A1c (> 8–10%) is associated with a 4- to 8-fold increase in major congenital anomalies:
   • Congenital Heart Defects (most common): Transposition of the Great Arteries (TGA), Ventricular Septal Defect (VSD), Coarctation of the Aorta, and hypertrophic cardiomyopathy with asymmetric septal hypertrophy.
   • Central Nervous System Anomalies: Anencephaly, spina bifida, and holoprosencephaly.
   • Caudal Regression Syndrome (Sacral Agenesis): Partial or complete absence of the sacrum and lower lumbar spine with lower extremity hypoplasia; occurs nearly 200 times more frequently in infants of diabetic mothers than in the general population.
2. Late Pregnancy Hyperglycemia (Second & Third Trimesters): Maternal glucose freely diffuses across the placenta via facilitated diffusion, but maternal insulin does not cross the placenta. In response to persistent fetal hyperglycemia, the fetal pancreas undergoes beta-cell hyperplasia and hypersecretion of fetal insulin.
   • Fetal insulin acts as a powerful anabolic growth factor, stimulating cellular hypertrophy, protein synthesis, and glycogen and lipid deposition.
   • Pedersen Hypothesis Consequences: Fetal macrosomia (birth weight > 4,000–4,500 g or > 90th percentile), organomegaly (hepatosplenomegaly, cardiomegaly), increased metabolic rate leading to fetal hypoxemia, increased erythropoietin production, and neonatal polycythemia (central hematocrit > 65%).
   • Postnatal Rebound Hypoglycemia: At delivery, the continuous transplacental supply of maternal glucose is abruptly terminated upon umbilical cord clamping. However, the neonate's hyperplastic pancreatic beta cells continue to secrete high levels of insulin, precipitating profound rebound hypoglycemia typically within 30 to 120 minutes of life.

---

Hypertensive Disorders of Pregnancy & Magnesium Exposure

Hypertensive disorders affect up to 10% of pregnancies and represent a leading cause of maternal and fetal morbidity.

Clinical Spectrum of Hypertensive Disorders

• Chronic Hypertension: Blood pressure ≥ 140/90 mmHg predating pregnancy or diagnosed prior to 20 weeks gestation.
• Gestational Hypertension: New-onset systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg after 20 weeks gestation in the absence of proteinuria or systemic signs.
• Preeclampsia: New-onset hypertension after 20 weeks accompanied by proteinuria (≥ 300 mg/24 hr or protein/creatinine ratio ≥ 0.3) OR signs of maternal end-organ dysfunction (thrombocytopenia < 100,000/μL, serum creatinine > 1.1 mg/dL, elevated transaminases to twice normal, pulmonary edema, or new cerebral/visual disturbances).
• Preeclampsia with Severe Features: Systolic BP ≥ 160 mmHg or diastolic BP ≥ 110 mmHg on two occasions at least 4 hours apart, or presence of progressive end-organ damage.
• Eclampsia: Development of new-onset grand mal seizures in a woman with preeclampsia.
• HELLP Syndrome: Severe variant characterized by Hemolysis (microangiopathic hemolytic anemia, elevated LDH), Elevated Liver enzymes (AST/ALT), and Low Platelets (< 100,000/μL).

Fetal & Neonatal Impact

Preeclampsia involves widespread maternal endothelial dysfunction and failure of normal trophoblastic remodeling of the spiral arteries. This causes chronic placental vasoconstriction, reduced intervillous blood flow, and placental infarction.

• Fetal Effects: Chronic intrauterine hypoxia, oligohydramnios, abnormal umbilical artery Doppler flow (absent or reversed end-diastolic velocity), asymmetric IUGR (head-sparing), and elevated risk of abruptio placentae.
• Neonatal Effects: Prematurity, polycythemia, thrombocytopenia, neutropenia, and elevated risk of perinatal asphyxia.

Maternal Magnesium Sulfate Therapy & Neonatal Hypermagnesemia

Intravenous Magnesium Sulfate ($MgSO_4$) is the standard of care for maternal seizure prophylaxis in severe preeclampsia/eclampsia and for fetal neuroprotection prior to early preterm birth (< 32 weeks).

• Magnesium freely crosses the placental barrier, achieving fetal serum levels equal to or exceeding maternal concentrations.
• Neonatal Manifestations of Hypermagnesemia (Serum $Mg^{2+} > 2.5\text{ mg/dL}$):
  1. Neuromuscular Depression: Generalized hypotonia ("floppy infant"), poor or absent suck reflex, weak cry, and depressed deep tendon and primitive reflexes (Moro, grasp).
  2. Cardiorespiratory Depression: Bradypnea, shallow respirations, apnea, delayed initiation of spontaneous breathing, and transient bradycardia.
  3. Gastrointestinal Hypomotility: Delayed passage of meconium (> 24–48 hours), abdominal distension, feeding intolerance, and functional paralytic ileus (meconium plug syndrome).
  4. Genitourinary: Transient urinary retention.
• Nursing Management: Provide respiratory support (supplemental oxygen, CPAP, or PPV if indicated), maintain thermal stability, monitor cardiorespiratory status, delay enteral feeding until bowel sounds and tone improve, and assist with IV calcium gluconate (10% solution) as a direct physiologic antagonist in rare cases of severe life-threatening neuromuscular blockade.

Maternal Infectious Diseases & Perinatal Transmission

Vertical transmission of maternal pathogens can occur transplacentally, intrapartum via ascending infection or contact with maternal blood and cervicovaginal secretions, or postpartum via human milk.

Group B Streptococcus (GBS / Streptococcus agalactiae)

GBS is the leading cause of early-onset neonatal sepsis and meningitis in high-income nations.

• Universal Screening: Rectovaginal culture screening is performed at 36 0/7 to 37 6/7 weeks gestation for all pregnant women unless GBS bacteriuria was detected earlier in the current pregnancy or the woman previously gave birth to an infant with invasive GBS disease.
• Adequate Intrapartum Antibiotic Prophylaxis (IAP): Defined as administration of intravenous Penicillin G (5 million units initial loading dose, then 2.5–3.0 million units IV every 4 hours until delivery) or intravenous Ampicillin (2 g initial loading dose, then 1 g IV every 4 hours) initiated ≥ 4 hours prior to delivery.
• In penicillin-allergic women: Cefazolin is used for low-risk allergies; clindamycin (if isolate is susceptible) or vancomycin (weight-based dosing) is used for high-risk anaphylaxis allergies.
• Indications for Empiric IAP without Culture: Preterm labor (< 37 0/7 weeks), prolonged rupture of membranes (≥ 18 hours), intrapartum maternal fever (≥ 38.0°C / 100.4°F), or history of a prior GBS-infected infant.

Herpes Simplex Virus (HSV)

Perinatal transmission occurs primarily during passage through an infected birth canal.

• Transmission Risk: Highest with primary maternal genital HSV infection acquired in late pregnancy (30% to 50% risk due to high viral shedding and lack of maternal neutralizing antibodies) compared to recurrent HSV (< 1% to 3% risk).
• Obstetric Management: If active genital herpes lesions or prodromal symptoms (vulvar tingling, burning) are present at the onset of labor or membrane rupture, an immediate cesarean delivery is indicated, ideally within 4 to 6 hours of membrane rupture.
• Neonatal HSV Classification:
  1. Skin, Eye, and Mouth (SEM) Disease: Localized vesicular skin lesions, keratoconjunctivitis; excellent prognosis if treated early, but untreated cases frequently progress to CNS or disseminated infection.
  2. Central Nervous System (CNS) Disease: Encephalitis, lethargy, irritability, seizures, CSF pleocytosis; high risk of long-term neurologic deficits.
  3. Disseminated Disease: Severe multiorgan failure, fulminant hepatitis, DIC, respiratory failure, shock; mortality exceeds 80% without antiviral therapy.
• Neonatal Treatment: High-dose intravenous Acyclovir (60 mg/kg/day divided every 8 hours) for 14 days (SEM) or 21 days (CNS/disseminated), followed by oral acyclovir suppressive therapy for 6 months.

Human Immunodeficiency Virus (HIV)

Universal opt-out antepartum screening combined with modern combination antiretroviral therapy (cART) has reduced perinatal transmission to < 1%.

• Delivery Management: If maternal viral load is > 1,000 copies/mL (or unknown) near delivery: Administer continuous intravenous Zidovudine (AZT) infusion during labor and perform a scheduled cesarean delivery at 38 weeks gestation prior to labor onset or rupture of membranes. If viral load is undetectable (< 50 copies/mL) on cART, vaginal delivery is appropriate.
• Intrapartum Precautions: Strictly avoid invasive procedures that breach fetal skin barriers, including fetal scalp electrodes, fetal scalp blood sampling, artificial rupture of membranes, and operative vacuum/forceps delivery.
• Postnatal Neonatal Prophylaxis: Initiate neonatal oral Zidovudine (AZT) within 6 to 12 hours of birth for 4 to 6 weeks (or multi-drug antiretroviral regimens for high-risk exposures). In high-resource countries, formula feeding is recommended to prevent vertical transmission through human milk.

Congenital Syphilis (Treponema pallidum)

Spiraling rates of maternal syphilis have caused a resurgence in congenital syphilis.

• Transmission & Pathophysiology: T. pallidum readily crosses the placenta after 9–10 weeks gestation, causing diffuse fetal vasculitis and inflammatory necrosis.
• Early Congenital Syphilis Manifestations (Birth to 2 Years):
  • Syphilitic Rhinitis ("Snuffles"): Copious, highly infectious serosanguinous or purulent nasal discharge.
  • Dermatologic: Maculopapular or vesiculobullous rash on palms and soles with desquamation, mucous patches, and condyloma lata.
  • Skeletal: Periostitis, osteochondritis, and symmetric osteolytic bone lesions of long bones (Wimberger sign) causing pseudoparalysis of Parrot.
  • Systemic: Hepatosplenomegaly, jaundice, generalized lymphadenopathy, Coombs-negative hemolytic anemia, and hydrops fetalis.
• Treatment: Intravenous Aqueous Crystalline Penicillin G (50,000 units/kg/dose IV every 12 hours for the first 7 days, then every 8 hours for a total of 10 days).

Hepatitis B Virus (HBV)

• Maternal HBsAg Positive: If a mother is positive for Hepatitis B surface antigen (HBsAg), the neonate must receive both Hepatitis B Vaccine (0.5 mL IM) and Hepatitis B Immune Globulin (HBIG 0.5 mL IM) within 12 hours of birth administered at separate anatomical sites (e.g., right and left anterolateral thighs). This dual post-exposure prophylaxis prevents 90% to 95% of vertical transmissions.

TORCH Congenital Infections Summary

Maternal Substance Exposure & Perinatal Toxicology

---

Placental & Umbilical Cord Abnormalities

Abnormalities in placental implantation or cord architecture can rapidly compromise fetal-neonatal hemodynamics.

Placental Pathology Comparison

+-----------------------------------------------------------------------------------------+
|                              PLACENTAL DISORDERS SPECTRUM                               |
|                                                                                         |
|   Placenta Previa           Placental Abruption               Vasa Previa               |
|   * Implantation over os    * Premature detachment            * Fetal vessels over os   |
|   * Painless bright bleeding* Painful dark bleeding/tetany    * Painless bleeding at ROM|
|   * Risk of hypovolemia     * Severe fetal hypoxemia/shock    * Rapid fetal exsanguinate|
+-----------------------------------------------------------------------------------------+

1. Placenta Previa: Implantation of the placenta overlying or adjacent to the internal cervical os. Characterized by painless, bright red maternal vaginal bleeding in the third trimester. Maternal bleeding is predominantly maternal in origin; however, the neonate is at risk for prematurity, hypovolemia, and anemia if placental integrity is disrupted during delivery.
2. Abruptio Placentae (Placental Abruption): Premature separation of a normally implanted placenta prior to delivery, frequently associated with preeclampsia, chronic hypertension, trauma, or cocaine use. Characterized by painful, dark red vaginal bleeding (or concealed hemorrhage), uterine hypertonicity/rigidity, and severe fetal distress (recurrent late decelerations, prolonged bradycardia).
   • Neonatal Impact: Severe perinatal asphyxia, metabolic acidemia, acute hemorrhagic shock, consumptive coagulopathy, and high perinatal mortality.
3. Placental Insufficiency: Chronic failure of the placenta to deliver adequate oxygen and nutrients, resulting in asymmetric IUGR ("head-sparing" where brain growth is preserved while liver and subcutaneous fat stores are depleted), oligohydramnios, loss of fetal subcutaneous tissue, and dry, peeling, meconium-stained skin.
4. Velamentous Cord Insertion & Vasa Previa:
   • In velamentous insertion, umbilical cord vessels insert into the fetal membranes rather than the placental mass and travel unprotected between the amnion and chorion.
   • When these membranous fetal vessels cross the internal cervical os below the presenting part, the condition is termed Vasa Previa.
   • Catastrophic Emergency: Spontaneous or artificial rupture of membranes shears these unprotected fetal vessels, resulting in rapid fetal exsanguination within minutes. Characterized by the classic triad: painless vaginal bleeding immediately upon membrane rupture, sudden severe fetal bradycardia or a sinusoidal heart rate pattern, and acute neonatal hypovolemic shock. Immediate emergency cesarean delivery and rapid neonatal resuscitation with emergent uncrossed O-negative packed red blood cells (10 mL/kg) and normal saline boluses are life-saving.